Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.920
-0.160 (-5.19%)
At close: Feb 21, 2025, 4:00 PM
3.000
+0.080 (2.74%)
After-hours: Feb 21, 2025, 5:59 PM EST
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $401.76 million as of February 21, 2025. Its market cap has increased by 131.78% in one year.
Market Cap
401.76M
Enterprise Value
273.24M
1-Year Change
131.78%
Ranking
Category
Stock Price
$2.92
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $401.76M, a decrease of -7.71%. That is a compound annual growth rate of -2.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 401.76M | 101.38% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |